The chemotherapy of pulmonary tuberculosis with pyrazinamide used alone and in combination with streptomycin, para-aminosalicylic acid, or isoniazid.

Suppr

超能文献

作者信息

SCHWARTZ W S, MOYER R E

出版信息

Am Rev Tuberc. 1954 Sep;70(3):413-22. doi: 10.1164/art.1954.70.3.413.

DOI:10.1164/art.1954.70.3.413

PMID:13189056

Abstract

摘要

相似文献

The chemotherapy of pulmonary tuberculosis with pyrazinamide used alone and in combination with streptomycin, para-aminosalicylic acid, or isoniazid.

Am Rev Tuberc. 1954 Sep;70(3):413-22. doi: 10.1164/art.1954.70.3.413.

Streptomycin, isoniazid, and para-aminosalicylic acid in the treatment of pulmonary tuberculosis.

Am Rev Tuberc. 1956 Jan;73(1):117-22. doi: 10.1164/artpd.1956.73.1.117.

Isoniazid and streptomycin in the treatment of pulmonary tuberculosis.

J Am Med Assoc. 1953 Jul 4;152(10):886-90. doi: 10.1001/jama.1953.03690100004002.

Clinical observations on the use of isoniazid in tuberculosis.

Dis Chest. 1954 Jun;25(6):611-21. doi: 10.1378/chest.25.6.611.

Prolonged chemotherapy in chronic pulmonary tuberculosis with combinations of isoniazid, para-aminosalicylic acid, and streptomycin.

Lancet. 1956 Jul 28;271(6935):165-9. doi: 10.1016/s0140-6736(56)91694-4.

Control study of comparative efficacy of isoniazid streptomycin-isoniazid, and streptomycin-para-aminosalicylic acid in pulmonary tuberculosis therapy.

Am Rev Tuberc. 1953 Jan;67(1):108-13. doi: 10.1164/art.1953.67.1.108.

Isoniazid in single and multiple drug regimens in the treatment of pulmonary tuberculosis of recent origin.

Am Rev Tuberc. 1955 Jun;71(6):841-59. doi: 10.1164/artpd.1955.71.6.841.

Toxicity of isonicotinic acid hydrazides in pulmonary tuberculosis; toxicity of isoniazid and iproniazid used alone and in combination with streptomycin or p-aminosalicylic acid.

AMA Arch Intern Med. 1954 Apr;93(4):541-9. doi: 10.1001/archinte.1954.00240280061006.

[Prolonged antibiotic therapy of pulmonary tuberculosis with isoniazid combined with streptomycin or PAS; indications for pneumothorax].

Sem Hop. 1955 Jul 2;31(40):2354-9.

[Treatment of pulmonary tuberculosis with streptomycin P.A.S. and isoniazid associated].

Maroc Med. 1954 Feb;33(345):101.

引用本文的文献

Essential Role of MHC II in the Antitubercular Efficacy of Pyrazinamide.

bioRxiv. 2025 Aug 21:2025.08.21.671522. doi: 10.1101/2025.08.21.671522.

Pyrazinamide Safety, Efficacy, and Dosing for Treating Drug-Susceptible Pulmonary Tuberculosis: A Phase 3, Randomized Controlled Clinical Trial.

Am J Respir Crit Care Med. 2024 Dec 1;210(11):1358-1369. doi: 10.1164/rccm.202401-0165OC.

Optimising pyrazinamide for the treatment of tuberculosis.

Eur Respir J. 2021 Jul 20;58(1). doi: 10.1183/13993003.02013-2020. Print 2021 Jul.

Clinical and toxicodynamic evidence that high-dose pyrazinamide is not more hepatotoxic than the low doses currently used.

Antimicrob Agents Chemother. 2010 Jul;54(7):2847-54. doi: 10.1128/AAC.01567-09. Epub 2010 May 3.

Pharmacokinetics-pharmacodynamics of pyrazinamide in a novel in vitro model of tuberculosis for sterilizing effect: a paradigm for faster assessment of new antituberculosis drugs.

Antimicrob Agents Chemother. 2009 Aug;53(8):3197-204. doi: 10.1128/AAC.01681-08. Epub 2009 May 18.

Hyperuricaemia due to pyrazinamide.

Br Med J. 1960 Sep 17;2(5202):830-2. doi: 10.1136/bmj.2.5202.830.

[Probable genetic loading of the population with "INH" (Isonicotinic hydrazide) (author's transl)].

Humangenetik. 1973;20(1):31-45. doi: 10.1007/BF00280873.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验